Skip to main content

Table 3 Five-year disease-free survival for stage III breast cancer

From: Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen

 

Chemotherapy + Placebo

Chemotherapy + Panagen

[25]

Patients

Survived patients

%

Patients

Survived patients

%

Survival, %

IIIA

2

1

 

50

7

4

 

57

47

IIIB

6

1

17

17

12

5

42

50

IIIC

0

-

-

6

4

67

 

Stage III, total

8

2

 

25

25

13

 

52

 
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us